ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673793 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673793; 2) Community: the network communities that were significantly associated with the response to NSC 673793; 3) Molecule: the relationships between components within communities and NSC 673793; 4) MDR: the compounds that were significantly associated with the NSC 673793.

NSC Compound Enrichment Correlation
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0139796580235792 0.47406505
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0139796580235792 0.26652316
NSC 300289 Pinafide 0.0139796580235792 0.18513242
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0139796580235792 0.28098379
NSC 328410 Camptothecin Derivative 0.0139796580235792 0.079509645
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0139796580235792 0.35520627
NSC 371777 Null 0.0139796580235792 0.30112322
NSC 629229 Null 0.0139796580235792 0.14504142
NSC 631371 N-(3,5-Dimethoxybenzyl)-4-methoxyaniline 0.0139796580235792 0.31601222
NSC 640735 3-(4-Methoxy-2-methylphenyl)naphthol [2,1-c]furan-1(3H)-one 0.0139796580235792 0.20753024
Total:103  Current:43    [First] [Prev] [Next] [Last]